Skip to main content
S&P 5007,718.60-0.38%DOW53,414.25-0.51%NASDAQ26,506.99-0.29%BTC$79,656.00-1.71%ETH$2,454.45-1.99%GOLD$4,477.20-1.38%OIL$91.22-0.09%
Smart Investors Daily
AC

NASDAQ · ACON

Aclarion, Inc.

Healthcare · Medical - Healthcare Information Services

$2.29

Up+$0.06 (+2.62%)

Updated Sep 5, 2026, 12:56 AM

SID Score

3.9/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.59M
P/E ratio
-0.22
Dividend yield
0.00%
52-week range
$1.95 – $12.03
Volume
46.49K
Avg. volume
889.41K

Price performance

ACON price history

1M range · 20 trading sessions · Daily adjusted prices

ACON closed at $2.29 after 20 trading sessions, up 0.00% for the selected period.

Last close
$2.29
Period change
+0.00%
Period low
$2.28
Period high
$2.77
Daily close
View OHLC price history
ACON OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 3, 2026$2.27$2.32$2.251$2.2946.49K
Sep 2, 2026$2.325$2.42$2.25$2.3163.71K
Sep 1, 2026$2.38$2.38$2.26$2.3340.49K
Aug 31, 2026$2.40$2.40$2.31$2.3537.13K
Aug 28, 2026$2.52$2.52$2.35$2.4035.25K
Aug 27, 2026$2.37$2.52$2.31$2.5254.08K
Aug 26, 2026$2.46$2.46$2.32$2.39103.62K
Aug 25, 2026$2.65$2.65$2.43$2.49175.09K
Aug 24, 2026$2.73$2.73$2.61$2.6649.05K
Aug 21, 2026$2.75$2.83$2.58$2.7144.41K
Aug 20, 2026$2.76$2.76$2.64$2.6945.72K
Aug 19, 2026$2.70$2.80$2.53$2.77124.99K
Aug 18, 2026$2.83$2.83$2.56$2.6080.85K
Aug 17, 2026$2.53$2.78$2.47$2.77182.3K
Aug 14, 2026$2.42$2.47$2.36$2.4635.7K
Aug 13, 2026$2.32$2.45$2.26$2.40106.87K
Aug 12, 2026$2.31$2.39$2.25$2.3266.9K
Aug 11, 2026$2.33$2.3699$2.28$2.2834.52K
Aug 10, 2026$2.28$2.40$2.27$2.3643.51K
Aug 7, 2026$2.32$2.36$2.23$2.2958.23K

Latest ACON news

The latest Smart Investors Daily articles mentioning ACON.

Stock researchCompany · Overview

ACON research

Overview

Company profile and research snapshot.

Company profile

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$23.46
Implied upside
—
Analysts
7
ACON recent ratings
DateFirmRatingTarget
May 29, 2026Ascendiant CapitalBuy—
Mar 25, 2026Ascendiant CapitalBuy—
Nov 20, 2025Ascendiant CapitalBuy—
Sep 19, 2025Ascendiant CapitalBuy—
Dec 13, 2024Maxim GroupHold—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Aug 20, 2026

Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site

University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical research and innovationTen sites now actively enrolling in CLARITY study, a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan® aims to become the gold standard in identifying sources of low back pain through

Yahoo · Jul 7, 2026

Aclarion Announces Texas Spine Care Center as New CLARITY Site

Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient's pain before recommending treatmentCLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., July 07, 2026 (GLO

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By